230 related articles for article (PubMed ID: 30059519)
1. The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells.
Messeha SS; Zarmouh NO; Mendonca P; Alwagdani H; Kolta MG; Soliman KFA
PLoS One; 2018; 13(7):e0201116. PubMed ID: 30059519
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effects of butein on cell proliferation and TNF-α-induced CCL2 release in racially different triple negative breast cancer cells.
Mendonca P; Horton A; Bauer D; Messeha S; Soliman KFA
PLoS One; 2019; 14(10):e0215269. PubMed ID: 31665136
[TBL] [Abstract][Full Text] [Related]
3. Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.
Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297339
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
Yuan Z; Jiang H; Zhu X; Liu X; Li J
Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
[TBL] [Abstract][Full Text] [Related]
5. Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells.
Messeha SS; Zarmouh NO; Antonie L; Soliman KFA
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955463
[TBL] [Abstract][Full Text] [Related]
6. Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer.
Arora R; Yates C; Gary BD; McClellan S; Tan M; Xi Y; Reed E; Piazza GA; Owen LB; Dean-Colomb W
PLoS One; 2014; 9(6):e98370. PubMed ID: 24896091
[TBL] [Abstract][Full Text] [Related]
7. Anti-Proliferative and Pro-Apoptotic Effects of
Alehaideb Z; AlGhamdi S; Yahya WB; Al-Eidi H; Alharbi M; Alaujan M; Albaz A; Tukruni M; Nehdi A; Abdulla MH; Matou-Nasri S
J Evid Based Integr Med; 2020; 25():2515690X20978391. PubMed ID: 33302699
[TBL] [Abstract][Full Text] [Related]
8. Effect of Diallyl Trisulfide on TNF-α-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells.
Kanga KJW; Mendonca P; Soliman KFA; Ferguson DT; Darling-Reed SF
Anticancer Res; 2021 Dec; 41(12):5919-5933. PubMed ID: 34848446
[TBL] [Abstract][Full Text] [Related]
9. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3.
Abd El-Hafeez AA; Khalifa HO; Mahdy EAM; Sharma V; Hosoi T; Ghosh P; Ozawa K; Montano MM; Fujimura T; Ibrahim ARN; Abdelhamid MAA; Pack SP; Shouman SA; Kawamoto S
Pharmacol Rep; 2019 Apr; 71(2):289-298. PubMed ID: 30826569
[TBL] [Abstract][Full Text] [Related]
11. Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways.
Hafeez BB; Jamal MS; Fischer JW; Mustafa A; Verma AK
Int J Cancer; 2012 Nov; 131(9):2175-86. PubMed ID: 22322442
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of gossypol mediating CCL2 and IL‑8 attenuation in triple‑negative breast cancer cells.
Messeha SS; Zarmouh NO; Mendonca P; Cotton C; Soliman KFA
Mol Med Rep; 2020 Aug; 22(2):1213-1226. PubMed ID: 32627003
[TBL] [Abstract][Full Text] [Related]
13. SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cells.
Choi EK; Kim SM; Hong SW; Moon JH; Shin JS; Kim JH; Hwang IY; Jung SA; Lee DH; Lee EY; Lee S; Kim H; Kim D; Kim YS; Choi YK; Kim HI; Choi HS; Cho SG; Kim JE; Kim KP; Hong YS; Lee WK; Lee JS; Kim TW; Ko SG; Jin DH
Mol Med Rep; 2016 Oct; 14(4):3955-60. PubMed ID: 27599791
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway.
Li J; Shen L; Lu FR; Qin Y; Chen R; Li J; Li Y; Zhan HZ; He YQ
Acta Pharmacol Sin; 2012 Feb; 33(2):242-9. PubMed ID: 22231395
[TBL] [Abstract][Full Text] [Related]
15. Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells.
Messeha SS; Zarmouh NO; Asiri A; Soliman KFA
Eur J Pharmacol; 2020 Oct; 885():173419. PubMed ID: 32750370
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel.
Gangapuram M; Mazzio EA; Redda KK; Soliman KFA
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299315
[TBL] [Abstract][Full Text] [Related]
17. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2.
Ahmad A; Banerjee S; Wang Z; Kong D; Sarkar FH
J Cell Biochem; 2008 Dec; 105(6):1461-71. PubMed ID: 18980240
[TBL] [Abstract][Full Text] [Related]
18. Eriocalyxin B induces apoptosis in human triple negative breast cancer cells via inhibiting STAT3 activation and mitochondrial dysfunction.
Riaz A; Rasul A; Hussain G; Zubair M; Samiullah K; Sarfraz I; Masood M; Jabeen F; Sultana T; Sultana S
Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2843-2848. PubMed ID: 32024623
[TBL] [Abstract][Full Text] [Related]
19. Pentagalloyl glucose inhibits TNF-α-activated CXCL1/GRO-α expression and induces apoptosis-related genes in triple-negative breast cancer cells.
Mendonca P; Alghamdi S; Messeha S; Soliman KFA
Sci Rep; 2021 Mar; 11(1):5649. PubMed ID: 33707603
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
